tiprankstipranks
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market
2162
Keymed Biosciences, Inc.
RESEARCH TOOLSreports
Want to see HK:2162 full AI Analyst Report?

Keymed Biosciences, Inc. (2162) Stock News & Sentiment

1 Followers
Keymed Biosciences Sets AGM to Approve Accounts, Board Changes and New Share Mandate
Premium
Company Announcements
Keymed Biosciences Sets AGM to Approve Accounts, Board Changes and New Share Mandate
22d ago
2162
Keymed Biosciences Details Gain and Capital Plans From Ouro Medicines Stake Disposal
Premium
Company Announcements
Keymed Biosciences Details Gain and Capital Plans From Ouro Medicines Stake Disposal
1M ago
2162
Keymed Biosciences boosts revenue on Kangyueda push while deepening R&D pipeline
Premium
Company Announcements
Keymed Biosciences boosts revenue on Kangyueda push while deepening R&D pipeline
2M ago
2162
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
Premium
Market News
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
2M ago
GSK
GILD
Keymed Biosciences to Realize Up to US$320 Million From Ouro Medicines Exit
Premium
Company Announcements
Keymed Biosciences to Realize Up to US$320 Million From Ouro Medicines Exit
2M ago
2162
Keymed Biosciences Sets March 26 Board Meeting to Approve 2025 Results and Consider Final Dividend
Premium
Company Announcements
Keymed Biosciences Sets March 26 Board Meeting to Approve 2025 Results and Consider Final Dividend
2M ago
2162
Keymed Gains US$45 Million Milestone as AstraZeneca Starts Phase III Trial of Core Cancer Drug
Premium
Company Announcements
Keymed Gains US$45 Million Milestone as AstraZeneca Starts Phase III Trial of Core Cancer Drug
2M ago
2162
More HK:2162 News >

2162 News on the Web

Keymed Biosciences Details Gain and Capital Plans From Ouro Medicines Stake Disposal
TipRanks News
Bullish
KeyBanc Sticks to Their Buy Rating for Keymed Biosciences, Inc. (2162)
TipRanks News
Neutral
Huatai Securities Remains a Buy on Keymed Biosciences, Inc. (2162)
TipRanks News
Bullish
Huatai Securities Keeps Their Buy Rating on Keymed Biosciences, Inc. (2162)
TipRanks News
Bullish
Keymed Biosciences, Inc. (2162) Receives a Buy from CLSA
TipRanks News
Bullish
Keymed Biosciences boosts revenue on Kangyueda push while deepening R&D pipeline
TipRanks News
Bullish
Keymed Biosciences to Realize Up to US$320 Million From Ouro Medicines Exit
TipRanks News
Bullish
Keymed Biosciences Sets March 26 Board Meeting to Approve 2025 Results and Consider Final Dividend
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
HK:2162
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:2162’s Media Buzz Sentiment?
1 articles about HK:2162 were published this week. In an average week, 1.75 articles are published.
    What is HK:2162’s weekly average amount of articles?
    In an average week, 1.75 articles about HK:2162 are published.
      What is HK:2162’s News Sentiment?
      100% of articles about HK:2162 were positive this week, compared to its sector average of 76%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        CGENCompugen
        PROKProKidney
        ROIVRoivant Sciences
        Showing the stocks with the most bullish news sentiment over the past week